Clinical Trial Update: An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports completion of an exploratory Phase 1/2 study of CARDIX-101 for chronic bradycardia, assessing safety and preliminary efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradycardia

Drugs mentioned

• CARDIX-101

Snippet

Sponsor: Cardix Therapeutics LLC | Conditions: Bradycardia | Phase 1, Phase 2 | Status: COMPLETED